Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca Set To Gain From New Asthma Drug
AstraZeneca Set To Gain From New Asthma Drug
AstraZeneca Set To Gain From New Asthma Drug
Submitted by
admin
on June 28, 2012 - 10:31am
Source:
Seeking Alpha
News Tags:
asthma
AstraZeneca
Rigel
JAK inhibitors
Amgen
GSK
JNJ
Eli Lilly
Merck
R256
Headline:
AstraZeneca Set To Gain From New Asthma Drug
Do Not Allow Advertisers to Use My Personal information
